Innovations In Clinical Neuroscience

Summit 2017

A peer-reviewed, evidence-based journal for clinicians in the field of neuroscience

Issue link: https://innovationscns.epubxp.com/i/901174

Contents of this Issue

Navigation

Page 2 of 21

ICNS Innovations in Clinical Neuroscience • November–December 2017 • Volume 14 • Number 11–12 • Supplement S3 JOURNAL STAFF Editor Amir H. Kalali, MD Professor of Psychiatry, University of California, San Diego, CA Executive Editor Elizabeth A. Klumpp Matrix Medical Communications, West Chester, PA Managing Editor Angela M. Saba M atrix Medical Communications, West Chester, PA Assistant Editor Julia E. Eckert Matrix Medical Communications, West Chester, PA A ssistant Editor F rank Hosking III M atrix Medical Communications, West Chester, PA Assistant Editor Austin K. Vitelli Matrix Medical Communications, West Chester, PA BUSINESS STAFF Matrix Medical Communications, West Chester, PA P resident/Group Publisher R obert L. Dougherty Vice President, Publisher Joseph J. Morris Vice President, Editorial Director Elizabeth A. Klumpp Vice President, Business Development and Finance Christine C. Franey Associate Director of Business Development Christopher Moccia Social Media and Grants Coordinator Emily A. Scullin Partner Patrick D. Scullin Editorial Queries Elizabeth A. Klumpp Phone: (484) 266-0702; E-mail: eklumpp@matrixmedcom.com Advertising Queries Robert L. Dougherty Phone: (484) 266-0702 ; E-mail: rdougherty@matrixmedcom.com Indexing PubMed Central, PsycINFO, CINAHL ® Plus with Full Text, Scopus, and Embase Innovations in Clinical Neuroscience, ISSN 2158-8333 (Print) and ISSN 2158- 8341(Online), is published electronically 6 times yearly by Matrix Medical Communications via www.innovationscns.com. To receive an e-mail when a new issue is available and/or to access full content online, please visit www.innovationscns.com and complete the online registration form. Registration and access are free to qualified professionals. Innovations in Clinical Neuroscience is not intended for patients or consumers. Copyright © 2017 Matrix Medical Communications. All rights reserved. Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Matrix Medical Communications, the editorial staff, or any member of the editorial advisory board. Matrix Medical Communications is not responsible for accuracy of dosages given in the articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Matrix Medical Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements. Matrix Medical Communications, LLC, 1595 Paoli Pike, Suite 201, West Chester, PA 19355, Phone 866.325.9975, Phone 484.266.0702, Fax 484.266.0726 VOL. 14, NO. 11–12 • NOVEMBER–DECEMBER 2017 • SUPPLEMENT NOVEMBER 16–19, 2017 • BOCA RATON, FL Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research that is being presented during CNS Summit 2017. The supplement is also available online by visiting www.innovationscns.com. This supplement is just a small representation of what has become the premier event each year in drug development. Over 500 leaders in the field are attending this year's CNS Summit to experience more enlightening talks and innovative reveals than ever before. Here at the CNS Summit, participants will discover the latest advances in pharmaceutical research and development, such as digital biomarkers, mobile medicine, and AI and machine learning, as well as witness the unveiling of several new innovative products and technologies. Additionally, through the proprietary CNS Summit One-to-One Meeting Platform, participants have the unique opportunity to network with the key stakeholders involved in the discovery and development of new compounds and therapies in medicine. The CNS Summit is committed to collaboration among all entities involved in drug development, and we believe collaboration and data sharing with those involved in research across a wide variety of disease states will create more opportunity for developing better, safer, and more accessible drugs universally and within all areas of healthcare. In this abstract supplement, we've organized CNS Summit 2017 poster abstracts into the following groups for your convenience and easy reference: • Biomarkers and Imaging • Digital Tools and Technology • Investigative Drug Compounds and Therapies • Mobile Technology • Patient Assessment and Adherence • Patient Recruitment • Placebo Response • Rater Assessment and Training • Trial Protocol You will also find an alphabetical index by author and poster title on pages 20 and 21 of this publication. We hope you find the CNS Summit 2017 poster abstract supplement informative and that it provides a useful snapshot of the research being presented at CNS Summit 2017. Make sure to mark your calendars for CNS Summit 2018, which will take place November 1 to 4, 2018, at the Boca Raton Resort in Florida. Visit www.cnssummit.org for more information. Hope to see you in Boca! As always, we welcome your feedback and participation. Sincerely, Amir Kalali, MD Editor, Innovations in Clinical Neuroscience ICNS

Articles in this issue

Links on this page

Archives of this issue

view archives of Innovations In Clinical Neuroscience - Summit 2017